Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptive, Non-inferiority Trial to Investigate Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial

NCT07788586 is registered in ClinicalTrials.gov with Oliver Cornely, MD as lead sponsor.

NCT NCT07788586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07788586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptive, Non-inferiority Trial to Investigate Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial
Lead sponsor
Oliver Cornely, MD
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
February 29, 2028
Enrollment
420 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

candidemia, invasive candidiasis